Harry R Munson, Jr

This inventor holds 21 USPTO granted patents, primarily in Pharmaceutical Chemistry. Top assignees: A. H. Robins Company, Incorporated, American Home Products Corporation. Active years: 1980-1996.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Harry R Munson, Jr. Retrieved from https://idiyas.com/inventor/harry-r-munson-jr

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 21

% Patents Active = 100.0

Average Co-Inventor Count = 2.0

ph-index = 8

Forward Citations = 253(Granted Patents)

Location History:

Richmond, VA (US) (1980 - 1989)
Durham, NC (US) (1991)
Leawood, KS (US) (1992 - 1993)
Loveland, OH (US) (1995 - 1996)

Company Filing History:

18 out of 218

A. H. Robins Company, Incorporated

patents

3 out of 1,567

American Home Products Corporation

patents

Years Active: 1980-1996

Loading Chart...

Areas of Expertise:

Anti-Influenza Agents

Azabicyclic Compounds

Benzamide Derivatives

Carboxylic Acid Amides

Heterocyclic Compounds

Therapeutic Treatment

Mucolytic Agents

Diabetic Complications

21 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 5519037 - N-cyanoamidine derivatives as anti-influenza agents (1996-05-21),

2. 5475012 - N-cyanoamidine derivatives as anti-influenza agents (1995-12-12),

3. 5380734 - N-cyanoamidine derivatives as anti-influenza agents (1995-01-10),

4. 5273972 - [(2-diakylaminomethyl)-3-quinuclidinyl]-benzamides and benzoates (1993-12-28),

5. 5244907 - Carbocyclic carboxylic acid amides and esters of azabicyclic compounds (1993-09-14),

6. 5236931 - 2-substituted benzamide and benzoate derivatives of 3-aminoquinuclidine (1993-08-17),

7. 5190953 - Heterocyclic carboxylic acid amides and esters of azabicyclic compounds (1993-03-02),

8. 5171753 - Derivatives of 2-amino-1-phenylethanol having antiulcer activity (1992-12-15),

9. 5137895 - 3-[N-aroyl(or thioaroyl)aminomethyl]-3-quinuclidinols (1992-08-11),

10. 5084460 - Methods of therapeutic treatment with (1992-01-28),

11. 5070095 - Substituted 4-(amidino)benzamides of 1-azabicyclo[2.2.2]octan-3- and (1991-12-03),

12. 4803200 - Substituted dialkanolamines, sulfur analogs and condensed 1,4-oxazine (1989-02-07),

13. 4717563 - 2-alkoxy-N-(1-azabicyclo(2.2.2)oct-3-yl) benzamides and thiobenzamides (1988-01-05),

14. 4604404 - Antiviral sulfonated naphthalene formaldehyde condensation polymers (1986-08-05),

15. 4593034 - 2-alkoxy-N-(1-azabicyclo[2.2.2]oct-3-yl)benzamides and thiobenzamides (1986-06-03),

Title: The Innovative Contributions of Harry R. Munson, Jr.

Introduction: Harry R. Munson, Jr., based in Leawood, Kansas, has made significant contributions to the field of pharmaceuticals, particularly in the development of anti-influenza agents. With an impressive portfolio of 21 patents, Munson's innovative work continues to impact medical science.

Latest Patents: Among his latest patents are the N-cyanoamidine derivatives as anti-influenza agents. One patent details that anti-influenza A activity was found in compounds characterized by specific formulas, wherein various components such as X and Z play crucial roles in their effectiveness. Another patent involves different configurations of N-cyanoamidine derivatives, emphasizing the versatility and potential of these compounds in combating influenza.

Career Highlights: Throughout his career, Munson has been associated with reputable companies such as A.H. Robins Company, Incorporated and American Home Products Corporation. His work has not only contributed to his personal achievements but has also furthered the research and development goals of these organizations.

Collaborations: Munson has collaborated with renowned colleagues like Gunnar E. Jagdmann, Jr. and Robert F. Boswell, which has enriched his research efforts and contributed to his innovative patents. These collaborations highlight the importance of teamwork in the advancement of scientific discovery.

Conclusion: Harry R. Munson, Jr.'s prolific patent portfolio and his dedication to developing anti-influenza agents underscore his valuable contributions to pharmaceutical research. His work not only exemplifies innovation but also showcases the power of collaboration in driving advancements in medicine.

Profile summary based on public USPTO records.

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]